• TRM (USD/COP)COP 3,461.92 +1.37% +COP 46.82Colombia's official exchange rate (Financial Superintendence), valid Nov 21 to Nov 23
  • EuroCOP 3,804.64 +1.37% +COP 51.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
  • Mexican pesoCOP 181.56 +1.37% +COP 2.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote

Alto Neuroscience's chief operating officer sold more than $2 million in shares

FinanceInternationalTradingViewAI summary
Image: TradingView

Alto Neuroscience's chief operating officer, Michael Conick Hanley Jr., sold 75,000 common shares for a total of $2,070,389, according to a Form 4 filed with the SEC. The transaction was made under a Rule 10b5-1 trading plan adopted on August 14, 2026. On November 16 he sold 70,000 shares in three transactions at a weighted average price of $27.68; on November 17, 2,104 shares at $26.816; and on November 18, 2,896 shares at $26.48. He no longer directly owns common shares of the company.

In 35 seconds

  • Hanley sold 75,000 common shares for $2,070,389 in total
  • The sale was made under a Rule 10b5-1 plan adopted on August 14, 2026
  • On November 16 he sold 70,000 shares in three transactions at a weighted average price of $27.68
Read the full story at TradingView

IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading